A citation-based method for searching scientific literature

Ilana Cass, Rae Lynn Baldwin, Taz Varkey, Roxana Moslehi, Steven A Narod, Beth Y Karlan. Cancer 2003
Times Cited: 340



Nicholas Turner, Andrew Tutt, Alan Ashworth. Nat Rev Cancer 2004
Times Cited: 1121




List of shared articles



Times cited

Epithelial ovarian cancer risk: A review of the current genetic landscape.
Nicola Flaum, Emma J Crosbie, Richard J Edmondson, Miriam J Smith, Dafydd G Evans. Clin Genet 2020
9

Mechanisms underlying acquired platinum resistance in high grade serous ovarian cancer - a mini review.
Mudra Binju, Monica Amaya Padilla, Terence Singomat, Pritinder Kaur, Yohan Suryo Rahmanto, Paul A Cohen, Yu Yu. Biochim Biophys Acta Gen Subj 2019
22

Role of BRCA Mutations in the Modulation of Response to Platinum Therapy.
Sanghamitra Mylavarapu, Asmita Das, Monideepa Roy. Front Oncol 2018
50

Genomic insights in gynecologic cancer.
Erika Roddy, Jocelyn Chapman. Curr Probl Cancer 2017
5


Clinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients.
Agnieszka Synowiec, Gabriel Wcisło, Lubomir Bodnar, Bohdan Górski, Jolanta Szenajch, Katarzyna Szarlej-Wcisło, Cezary Szczylik. Hered Cancer Clin Pract 2016
9

Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.
Renaud Sabatier, Elise Lavit, Jessica Moretta, Eric Lambaudie, Tetsuro Noguchi, François Eisinger, Elisabeth Cherau, Magali Provansal, Doriane Livon, Laetitia Rabayrol,[...]. Fam Cancer 2016
4

Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches.
Ibrahim H Sahin, Maeve A Lowery, Zsofia K Stadler, Erin Salo-Mullen, Christine A Iacobuzio-Donahue, David P Kelsen, Eileen M O'Reilly. Expert Rev Gastroenterol Hepatol 2016
24

Olaparib for the treatment of ovarian cancer.
E Bornstein, A Jimeno. Drugs Today (Barc) 2016
3

Ovarian cancer: Status of homologous recombination pathway as a predictor of drug response.
Nicolas De Picciotto, Wulfran Cacheux, Arnaud Roth, Pierre O Chappuis, S Intidhar Labidi-Galy. Crit Rev Oncol Hematol 2016
32

Paclitaxel is necessary for improved survival in epithelial ovarian cancers with homologous recombination gene mutations.
Stephanie Jean, Jiaqi Li, Dionyssios Katsaros, Bradley Wubbenhorst, Kara N Maxwell, Lauren Fishbein, Michael W McLane, Chiara Benedetto, Emilie Marion Canuto, Nandita Mitra,[...]. Oncotarget 2016
3

Synthetic lethality: the road to novel therapies for breast cancer.
Kiranjit K Dhillon, Ilirjana Bajrami, Toshiyasu Taniguchi, Christopher J Lord. Endocr Relat Cancer 2016
12


Olaparib in the management of ovarian cancer.
Kristin Bixel, John L Hays. Pharmgenomics Pers Med 2015
31